These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37816181)

  • 21. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
    Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
    Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview of Recent Patents and Patented Technology Platforms Based on Co-Processed Excipients.
    Kaushik D; Goel E; Verma R; Pandey P; Purohit D; Mittal V; Kumar K; Rahman MH
    Recent Adv Drug Deliv Formul; 2021; 15(1):3-14. PubMed ID: 33397276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive review on pharmaceutical excipients.
    Pockle RD; Masareddy RS; Patil AS; Patil PD
    Ther Deliv; 2023 Jul; 14(7):443-458. PubMed ID: 37464784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
    Patel KT; Chotal NP
    Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basics: Excipients Used in Nonsterile Compounding, Part 1.
    Allen LV
    Int J Pharm Compd; 2019; 23(4):305-311. PubMed ID: 31315082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choosing a medication brand: Excipients, food intolerance and prescribing in older people.
    Page A; Etherton-Beer C
    Maturitas; 2018 Jan; 107():103-109. PubMed ID: 29169573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selecting Excipients Forming Therapeutic Deep Eutectic Systems-A Mechanistic Approach.
    Wolbert F; Brandenbusch C; Sadowski G
    Mol Pharm; 2019 Jul; 16(7):3091-3099. PubMed ID: 31095911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of presence of excipients in drug analysis in fed-state gastric biorelevant media.
    Baxevanis F; Kuiper J; Fotaki N
    Eur J Pharm Biopharm; 2018 Oct; 131():178-188. PubMed ID: 30110669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basics of compounding foam dosage forms.
    Allen LV
    Int J Pharm Compd; 2013; 17(4):312-22. PubMed ID: 24261147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
    Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
    Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From single excipients to dual excipient platforms in dry powder inhaler products.
    Shur J; Price R; Lewis D; Young PM; Woollam G; Singh D; Edge S
    Int J Pharm; 2016 Dec; 514(2):374-383. PubMed ID: 27262269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y; Wilson L
    PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into Novel Excipients of Self-Emulsifying Drug Delivery Systems and Their Significance: An Updated Review.
    Rani ER; Radha GV
    Crit Rev Ther Drug Carrier Syst; 2021; 38(2):27-74. PubMed ID: 33639067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of common pharmaceutical excipients on the gut microbiota.
    Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ensuring Product Stability - Choosing the Right Excipients.
    Veronica N; Heng PWS; Liew CV
    J Pharm Sci; 2022 Aug; 111(8):2158-2171. PubMed ID: 35526577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding.
    Mulder K
    Int J Pharm Compd; 2021; 25(3):211-216. PubMed ID: 34125711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basics of compounding: basics of compounding with aliquots, dilutions, and concentrates.
    Allen LV
    Int J Pharm Compd; 2010; 14(6):508-10. PubMed ID: 23965655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
    Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
    Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.